4Prasad Verma P R, Chandak A R. Development of matrixcontrolled transdermal delivery systems of pentazocine : Invitro/in vivo performance[ J] . Acta pharmaceutica,2009,59(2) :171-186.
5Parkin Smith G F, Norman I J, Briggs E, et al. A struc-tured protocol of evidence-based conservative care com-pared with usual care for acute nonspecific low back pain :a randomized clinical trial [ J ]. Arch Phys Med Rehabil,2012,93(1) :ll-20.
6Dieterich M,Muller Jordan K,Stubert J,et al. Pain man-agement after cesarean : a randomized controlled trial ofoxycodone versus intravenous piritramide [ J ]. Arch Gyne-col Obstet, 2012,286(4) :859-865.
7Behdad S, Sekhavat L, Ayatollahi V, et al. Usporedbaposlijeoperacijskog analgezijskog ucinka potkozne prim-jene tramadola i bupivakaina u bolesnica podvrgnutih car-skom rezu[ J]. Acta Clinica Croatica, 2013 ,52 (1) : 93-98.
8fltak Karakaya i, Yuksel i,Akbayrak T, et al. Effects ofphysiotherapy on pain and functional activities after cesar-ean delivery [ J]. Arch Gynecol Obstet, 2012,285 ( 3 ):621-627.
9Suzuki T, Oshimi M , Tomono K, et al. Investigation oftransport mechanism of pentazocine across the blood - brain barrier using the In Siturat brain perfusion technique[ J]. J Pharm Sci, 2002,91(11):2346-2353.
10Sugai N, Yajima C, Chinzei M,et al. Postoperative painre-lief by patient controlled analgesia using intravenouspentazocine[ J]. Masui,1995 ,44 (2 ) :216-220.
